Last updated on May 2020

EMPA-KIDNEY (The Study of Heart and Kidney Protection With Empagliflozin)

Brief description of study

The primary aim of the study is to investigate the effect of empagliflozin on kidney disease progression or cardiovascular death versus placebo on top of standard of care in patients with pre-existing chronic kidney disease

Clinical Study Identifier: NCT03594110

Find a site near you

Start Over

Kelowna General Hospital

Kelowna, BC Canada
  Connect »